{
    "code": 0,
    "data": [
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "The Company has enclosing copy of newspaper advertisement     of financial results for the quarter ended 31.12.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07c6d55f-7722-41a0-95cc-c8ff9538f19d.pdf",
            "news_date": "2026-02-10 11:56:03"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Quarter Ended 31.12.2025",
            "news_body": "Result for the quarter ended 31.12.2025",
            "news_id": "10adf074-5a27-4131-98f9-1d5df4092719",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=313c042f-551a-4c90-9e2f-52c95234efeb.pdf",
            "news_date": "2026-02-09 13:39:04",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results Quarter Ended 31.12.2025",
            "news_body": "Result for the quarter ended 31.12.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=313c042f-551a-4c90-9e2f-52c95234efeb.pdf",
            "news_date": "2026-02-09 13:39:04"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d94c615d-8f11-426d-befd-fb213d5fbc7e.pdf",
            "news_date": "2026-02-09 13:35:54"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation To Consider And Adopt The Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended December 31 2025",
            "news_body": "Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Board Meeting intimation to consider and adopt the unaudited financial results for the 3rd quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82d2eeb9-d4ac-439b-ae64-928b98a113d4.pdf",
            "news_date": "2026-01-14 10:28:15"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Report On Re-Lodgement Of Transfer Requests Of Physical Shares Dec 2025",
            "news_body": "The Company has enclosed herewith report on relodgement of shares for the month of December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4de77d38-db18-4b90-a67c-0e19dc4bebef.pdf",
            "news_date": "2026-01-05 10:17:40"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "The Company has enclosing herewith certificate recived from RTA under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31.12.2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d6316e6-a16d-464f-b624-73ff63026791.pdf",
            "news_date": "2026-01-02 10:53:33"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The Company has enclosed herewith intimation for closing of trading window for the quarter ended 31.12.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e06068e-975f-498b-a395-063c521fd405.pdf",
            "news_date": "2025-12-22 13:25:25"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Report On Re-Lodgement Of Transfer Requests Of Physical Shares Nov 2025",
            "news_body": "The Company enclosing herewith RTA report on relodgement of trasnfer request of physical shares for the month Nov 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19df6f86-6509-4fba-a181-b199c76395e6.pdf",
            "news_date": "2025-12-03 12:48:21"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Report On Re-Lodgement Of Transfer Requests Of Physical Shares Oct 2025",
            "news_body": "The Company has enclosed herewith re-lodgement certificate received from RTA.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f818a3d-6513-4608-9083-0d35d3a11466.pdf",
            "news_date": "2025-11-18 10:28:49"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "The Company has enclosed herewith copy of newspapers advertisement for financial results for the quarter and half year ended 30.09.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4bd57d1-e9ed-4843-af95-734f87968ccc.pdf",
            "news_date": "2025-11-05 12:05:19"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result Sept 2025",
            "news_body": "Result Sept 2025",
            "news_id": "14062eb4-bff1-4dcd-8f9b-59d589960245",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b8dc552-b44d-46a8-a0a4-4c3f57ba8b59.pdf",
            "news_date": "2025-11-04 13:36:45",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Result Sept 2025",
            "news_body": "Result Sept 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b8dc552-b44d-46a8-a0a4-4c3f57ba8b59.pdf",
            "news_date": "2025-11-04 13:36:45"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a57bd6de-89c7-4ea8-a95b-f1cf172e0f51.pdf",
            "news_date": "2025-11-04 13:33:47"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For The Quarter Ended 30.09.2025.",
            "news_body": "Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2025 inter alia to consider and approve The Company has enclosed herewith Board Meting Intimation for quarter ended 30.09.2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3eabef63-67ae-44d2-becf-860ed2a70210.pdf",
            "news_date": "2025-10-16 10:20:40"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Report On Re-Lodgement Of Transfer Requests Of Physical Shares",
            "news_body": "The Company has received Certificate for Re lodgment of physical shares for the month of Sept 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de48d6d2-6940-463e-9215-9cda9442b7cb.pdf",
            "news_date": "2025-10-08 17:57:49"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "The Company has enclosed herewith certificate received from RTA for the quarter ended 30.09.2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f993b654-c077-46c3-b338-bdd313de7378.pdf",
            "news_date": "2025-10-08 15:35:30"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "The Company has enclosing herewith voting result and scrutinizer report for 33 rd AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e09c6d79-23a8-4d0b-9acf-886acd1f9ba1.pdf",
            "news_date": "2025-09-27 17:14:07"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "The Company has enclosed herewith proceedings of 33rd Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4e4b033-b008-4f65-ae4e-38f2aa3ab133.pdf",
            "news_date": "2025-09-26 12:47:12"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The Company has enclosed herewith intimation of closure of trading window for quarter and half year ended 30.09.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dc555e6-006e-4eef-8d15-92e073beb6de.pdf",
            "news_date": "2025-09-23 11:01:30"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Report On Re-Lodgement Of Transfer Requests Of Physical Shares",
            "news_body": "The Company has enclosed herewith RTA Report on re-lodgement of transfer requests of physical shares for the period up to 31.08.2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a272e6b-3fb5-4eba-99a9-2b15a264674e.pdf",
            "news_date": "2025-09-11 12:17:03"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "The Company has enclosed herewith copy of newspapers published in business standard and prajasakti w.r.t. Notice of 33rd Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2ae103f-af1a-4ee0-88bf-cf3cbc5ef3ca.pdf",
            "news_date": "2025-08-29 10:49:18"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 33Rd Annual General Meeting Of The Company",
            "news_body": "The Company has enclosed herewith notice of 33rd Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92e9df73-6c7b-441f-b9a6-62b3648df8fe.pdf",
            "news_date": "2025-08-28 14:48:36"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "The Company  has enclosed herewith copy of Annual Report for the financial year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59127f13-54f6-4581-9967-f636cf34f159.pdf",
            "news_date": "2025-08-28 12:40:02"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "The Company has enclosed herewith copy of newspaper publication of unaudited financial results for the quarter ended 30.06.2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a0105df-c01a-424c-9c9c-3a115eb8376e.pdf",
            "news_date": "2025-08-08 12:25:54"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Board Comments On Fine Levied By Exchanges",
            "news_body": "The Company has enclosed herewith comments of Board on fine levied by Exchanges",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=517ffcd7-0b0f-4232-82fb-438107e85e91.pdf",
            "news_date": "2025-08-07 16:02:04"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Intimation respect to change in management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73a7e500-af7e-4ae9-b1b5-1f380ae4de27.pdf",
            "news_date": "2025-08-07 14:30:53"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result",
            "news_body": "result",
            "news_id": "1a3e9958-3ca0-4728-abb8-cc8d2fad954d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b376f475-d9f2-40b3-b245-3eb0be430658.pdf",
            "news_date": "2025-08-07 14:28:27",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Result",
            "news_body": "result",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b376f475-d9f2-40b3-b245-3eb0be430658.pdf",
            "news_date": "2025-08-07 14:28:27"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board meeting dated 07.08.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05b779e6-c5bd-4d9b-a1dc-1b7cbf4fe55b.pdf",
            "news_date": "2025-08-07 14:13:51"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "The Company has enclosing herewith resignation letter received from Mr. Jitendra Shah Managing Director & CEO",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22f21789-ed35-45ec-a787-129c2b7d3f31.pdf",
            "news_date": "2025-07-25 16:00:26"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 7Th August 2025",
            "news_body": "Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve The Company has enclosed herewith intimation of board meeting to be held on 7th August 2025 inter-alia to consider and approve the unaudited financial results for the quarter ended 30.06.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cb5061f-893d-4e67-94ec-643cec8e54f1.pdf",
            "news_date": "2025-07-22 11:19:57"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "The Company has enclosed herewith certificates received from RTA under reg. 74(5) of SEBI DP Regulations 2018 for the quarter ended 31.03.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8eafe1b6-63ad-4508-ab1a-bfa656f336a0.pdf",
            "news_date": "2025-07-03 10:41:40"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The Company has enclosed herewith intimation for closure of trading window for the quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e16696f-2712-4c05-89f5-0119df567285.pdf",
            "news_date": "2025-06-23 12:04:54"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "The Company has enclosing herewith Annual Secretarial Compline Report for the year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81017668-58d8-4f58-9b3d-2f4e91020804.pdf",
            "news_date": "2025-05-28 15:44:02"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "The Company has enclosing herewith copy of newspaper publication.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5be7733c-a822-4801-b42e-d23b674a9009.pdf",
            "news_date": "2025-05-21 10:28:53"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result For The Year Ended 31.03.2025",
            "news_body": "Result for the year ended 31.03.2025",
            "news_id": "dfe74a58-3ce8-4ad8-a679-90066fb710aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b201056e-dfaf-46b1-b988-47d6e267ae68.pdf",
            "news_date": "2025-05-20 14:13:50",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Result For The Year Ended 31.03.2025",
            "news_body": "Result for the year ended 31.03.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b201056e-dfaf-46b1-b988-47d6e267ae68.pdf",
            "news_date": "2025-05-20 14:13:50"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 20Th May 2025",
            "news_body": "Outcome of Board Meeting held on 20.05.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bafaf5f2-c6f1-4a6e-818d-69cc5891429c.pdf",
            "news_date": "2025-05-20 14:08:53"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for To Consider And Approved Audited Financial Results For 4Th Quarter And Year Ended 31.03.2025",
            "news_body": "Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve to consider and approved audited financial results for 4th quarter and year ended 31.03.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=515e390d-7762-4b10-a18d-ccb3b02c5912.pdf",
            "news_date": "2025-05-07 13:29:11"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "The Company has enclosed herewith compliances certificate under Reg. 74 (5) of SEBI DP Regulations 2018 for the quarter ended 31.03.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e543d13d-0cf9-45b1-a27f-3385336743b1.pdf",
            "news_date": "2025-04-02 15:39:10"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "The Company has enclosed herewith voting results under reg 44 along with scrutinizer Report for the postal ballot notice dated 4th February 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c08b0ecf-9071-4dee-b324-12b7274459ac.pdf",
            "news_date": "2025-03-31 12:41:35"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "The Company has enclosed herewith intimation for completion of tenure of Mr. Satish Khivsara as an Independent Director",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e201dc9-1105-4b64-bdb0-a210239115a0.pdf",
            "news_date": "2025-03-24 10:38:52"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The Company has enclosed herewith intimation for closure of trading window for the year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf573f86-7f3e-4e3d-96f7-054e1b7cf9d7.pdf",
            "news_date": "2025-03-18 14:59:27"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "The Company has enclosing herewith intimation for completion of Tenure of Mrs. Malati Tangirala as an Independent Director of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=668dddea-6dbd-41f8-91ec-2fb4e348026a.pdf",
            "news_date": "2025-03-10 13:38:28"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "The Company has enclosed herewith Notice published in the Newspapers in respect of Postal Ballot Notice dated 4th February 2025 and e-voting details for postal ballot.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27b2ef3a-59f9-423f-969d-712fb700638a.pdf",
            "news_date": "2025-02-26 11:08:41"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "The Company has enclosing herewith Postal Ballot Notice seeking appointment of Independent Directors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38685820-5b59-41d5-9b34-540adebbf0e3.pdf",
            "news_date": "2025-02-24 15:15:06"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "The Company has enclosing herewith intimation for completion of tenure of Mr. Raj Kamal Prasad Verma w.e.f 13th February 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=960dea52-a320-4025-a1b9-7983ead9a85d.pdf",
            "news_date": "2025-02-11 15:53:25"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Order Received From Andhra Pradesh Pollution Control Board",
            "news_body": "Order received from Pollution Control Board",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c5f8b8c-efc2-4599-84d7-3d2ce806fdf7.pdf",
            "news_date": "2025-02-10 09:37:16"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Award of Order / Receipt of Order",
            "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
            "news_body": "Order received from Andhra Pradesh Pollution Control Board",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb5cb8c2-4ac6-4da5-bf56-07bd264e2bd3.pdf",
            "news_date": "2025-02-10 09:26:55"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "The Company has enclosing herewith copy of  Unaudited Financial Results for the quarter and nine months ended 31st December 2024  as published in Newspapers on 5th February 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3cd20f6-19e4-4799-a5c3-ecf509bdee4d.pdf",
            "news_date": "2025-02-05 10:52:24"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Reconstitution Of Various Committees Of The Board Of Company",
            "news_body": "The Company has enclosing herewith intimation regarding reconstitution of various committees of the Board",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e20a82e-7482-4fad-8dc1-b7d68d539e4b.pdf",
            "news_date": "2025-02-04 15:01:55"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "The Company has appointed Mr. P M Kathariya Ms. Dipti Shah Mr. Satyaprakash Chigurupati and Mr. Sumanth Karlapudi as Independent Directors of the Company w.e.f. 4th February 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=780c4984-f680-4a17-b150-ce577460d0ed.pdf",
            "news_date": "2025-02-04 14:44:04"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "The Company has enclosing herewith Integrated Financial Report for the quarter ended 31.12.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f8fdd7a-24a3-4245-a618-bd1d1dc3a529.pdf",
            "news_date": "2025-02-04 14:37:55"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For The Quarter Ended 31.12.2024",
            "news_body": "Financial Result for the quarter ended 31.12.2024",
            "news_id": "14536e78-f6ab-4338-88f2-f98d16986d00",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e74a119-da6b-4611-a29d-c4166413b867.pdf",
            "news_date": "2025-02-04 14:05:43",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Result For The Quarter Ended 31.12.2024",
            "news_body": "Financial Result for the quarter ended 31.12.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e74a119-da6b-4611-a29d-c4166413b867.pdf",
            "news_date": "2025-02-04 14:05:43"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting held on 04.02.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40c02271-856c-4c90-bafe-6f3903bd9c12.pdf",
            "news_date": "2025-02-04 13:57:47"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve The Company has enclosing herewith prior intimation of the Board Meeting to be held on 4th February 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70acce13-0682-4c11-aecc-eb2a488a6594.pdf",
            "news_date": "2025-01-15 10:37:00"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Governance)",
            "caption": "Integrated Filing (Governance)",
            "news_body": "The Company has enclosing herewith report on integrated  filing (Governance) for the quarter ended 31.12.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3bf88ffe-eeda-4466-a9c5-bfc35355e57c.pdf",
            "news_date": "2025-01-13 12:58:10"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "The Company has enclosing herewith RTA certificate received  pursuant to  reg 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=074914f3-8c27-43e4-8084-4ba45ea96b59.pdf",
            "news_date": "2025-01-02 17:45:36"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "Completion of tenure of Mr. Venkata Lakshmi Prasad Gundapaneni as an Independent Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=558df3f5-c181-4c01-9eb2-20f0b3f99cce.pdf",
            "news_date": "2024-12-31 10:42:18"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Reply To Clarification Sought On Price Movement",
            "news_body": "As per Letter attached",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=685f5d15-b80f-4508-b236-47a641d33d21.pdf",
            "news_date": "2024-11-28 12:04:23"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Krebs Biochemicals & Industries Ltd",
            "news_body": "The Exchange has sought clarification from Krebs Biochemicals & Industries Ltd on November 28, 2024, with reference to Movement in Price.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2024-11-28 11:07:29"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation for publication of financial results in the newspapers",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0632b2eb-caf8-41ea-981c-8a70ff854d63.pdf",
            "news_date": "2024-11-12 13:41:16"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For The Quarter And Half Year Ended  30.09.2024",
            "news_body": "Financial Result for the quarter and half year ended 30.09.2024",
            "news_id": "69979e47-8459-44b8-8313-f1056f2cc12d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57c50ab2-9d75-4106-b979-4d338fa769d4.pdf",
            "news_date": "2024-11-11 13:39:36",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Financial Result For The Quarter And Half Year Ended  30.09.2024",
            "news_body": "Financial Result for the quarter and half year ended 30.09.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57c50ab2-9d75-4106-b979-4d338fa769d4.pdf",
            "news_date": "2024-11-11 13:39:36"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Metting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b89ac2a6-4b47-4d3c-979a-55fc97e2cb55.pdf",
            "news_date": "2024-11-11 13:36:46"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting",
            "news_body": "KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 ,inter alia, to consider and approve Intimation of Board Meeting to be held on 11th November 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74c61aa9-a56f-4dff-9093-78f3d432a9f9.pdf",
            "news_date": "2024-10-28 11:53:05"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "The Company enclosing herewith copy of certificate under regulation 74 (5) of SEBI (DP) Regulations 2018  received from Kfintech Technologies Limited for the quarter ended 30.09.2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6520e8d-a1f6-4ea0-87d5-b1b089f32f62.pdf",
            "news_date": "2024-10-04 16:22:14"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer''s Report",
            "news_body": "The company enclosed herewith scrutinizer report and voting results of 32nd Annual General Meeting held on 27th September 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6555bdb1-293a-44fa-8ce2-9ca11403c2b9.pdf",
            "news_date": "2024-09-28 19:49:11"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "The Company enclosed herewith proceedings of 32nd Annual General Meeting held on 27th September 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f10b693-9e83-4d0f-ab1b-16076bec66ef.pdf",
            "news_date": "2024-09-27 15:22:44"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The trading window for dealing in securities of the Company will be remained closed w.e.f. close of  business hours on 30th September 2024 untill 48  hours after declaration of unaudited financial results for the quarter and half year ended 30th September 2024 for promoter, designated person, and their immediate relatives and all connected persons.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59ee656c-0939-4ed3-99c1-3cadcebd3906.pdf",
            "news_date": "2024-09-23 10:44:35"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "The Company enclosed herewith notice published in the newspapers issued to shareholders with respect to  Notice of 32nd AGM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1439a13-1324-4e91-9b24-18b2dbb9c417.pdf",
            "news_date": "2024-09-04 10:50:34"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Notice Of 32Nd Annual General Meeting Of The Company",
            "news_body": "The Company informed that the 32nd Annual General Meeting  will be held on Friday, 27th September 2024 at 11:30 am at the registered office of the company at Kothapalli (v), Kasimkota (M), Anakpalli(D), Vishakapatanam, Andhra Pradesh.- 531031.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1be8b29c-1dec-4ba8-942a-983b06b94038.pdf",
            "news_date": "2024-09-02 17:32:03"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "The Company enclosed herewith copy of Annual Report for the financial year ended 31st March 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ce97cb1-7c60-4ea0-a80a-19d278c92fdb.pdf",
            "news_date": "2024-09-02 12:20:26"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Reg 30 of the SEBI (LODR) Regulations 2015, we are enclosed herewith notice published in the newspapers in respect of prior intimation of 32nd Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86ebd9cc-c731-4dbc-bd32-52e375297612.pdf",
            "news_date": "2024-08-30 11:01:14"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "The Company enclosed herewith, copies of newspaper publication of financial results for quarter ended 30th June 2024 as published in newspapers''.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b080162-e394-4499-8a56-faf92f2c3419.pdf",
            "news_date": "2024-08-08 12:08:12"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30.06.2024",
            "news_body": "Financial Results for the quarter ended 30.06.2024",
            "news_id": "43b6305a-ac46-41da-b05f-74fcfaa0ffe9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=604bc41c-a573-4e66-a858-f2ce04f2ed34.pdf",
            "news_date": "2024-08-07 13:37:40",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30.06.2024",
            "news_body": "Financial Results for the quarter ended 30.06.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=604bc41c-a573-4e66-a858-f2ce04f2ed34.pdf",
            "news_date": "2024-08-07 13:37:40"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 07.08.2024",
            "news_body": "Outcome of Board Meeting dated 07.08.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5235422a-e4bf-4e32-b68d-4fd81c4774e6.pdf",
            "news_date": "2024-08-07 13:29:43"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting Under Reg 29 Of The SEBI (LODR) Regulations, 2015",
            "news_body": "KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 ,inter alia, to consider and approve The Company has informed that the meeting of Board of Directors of the Company is schedule on 07/08/2024 inter alia to consider and approve Unaudited Financial Results for the quarter ended 30th June 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48d495d4-0668-48e9-99c0-af6ab6ecd39d.pdf",
            "news_date": "2024-07-19 13:15:30"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "In compliances with Reg 74 (5) of SEBI (DP) Regulations, we are enclosed herewith certificates received from RTA of the Company for the quarter ended 30.06.2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c02ff6f4-ea65-489f-a042-b6bec3ea2f3c.pdf",
            "news_date": "2024-07-09 11:02:54"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for closure of trading window for the quarter ended 30th June 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=951cdbfd-209e-48d7-a0b3-307ec12578ea.pdf",
            "news_date": "2024-06-21 11:18:04"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Secretarial Compliance Report for the year ended 31.03.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=575ab43b-e776-4d8d-a472-0a12a4fb2617.pdf",
            "news_date": "2024-05-27 14:58:38"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2cc45e6-a43b-45bc-9750-fd67c18fac00.pdf",
            "news_date": "2024-05-22 11:49:41"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Appointment of Company Secretary",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0ce7ebc-7c26-473a-beff-7f854503434a.pdf",
            "news_date": "2024-05-21 15:51:23"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Year Ended 31.03.2024",
            "news_body": "Financial Results for the year ended 31.03.2024",
            "news_id": "f5e10bdd-8c69-491d-830f-b8655d9497b6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8d54b69-9127-4847-904c-c3aa7dac8bda.pdf",
            "news_date": "2024-05-21 15:50:20",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Year Ended 31.03.2024",
            "news_body": "Financial Results for the year ended 31.03.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8d54b69-9127-4847-904c-c3aa7dac8bda.pdf",
            "news_date": "2024-05-21 15:50:20"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting dated 21.05.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff054f52-6989-4d0b-953b-4f37bb0aabb1.pdf",
            "news_date": "2024-05-21 15:36:41"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Tuesday, May 21, 2024, Inter-Alia, To Consider And Adopt The Audited Financial Results For The 4Th Quarter And Financial Year Ended 31St March, 2024.",
            "news_body": "KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 ,inter alia, to consider and approve Audited Financial Results for the 4th quarter and financial year ended 31st March, 2024. `",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cdb2e20-6191-4679-9ac6-35ed91ea4a77.pdf",
            "news_date": "2024-05-08 11:13:56"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Reg. 40 (10) - PCS Certificate for Transfer / Transmission / Transposition",
            "caption": "Submission Of Certificate Under Reg. 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31.03.2024",
            "news_body": "Submission of certificate under Reg 40(9) of SEBI (LODR) Regulations, 2015 for the year ended 31.03.2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2812e5b-9f45-4691-a303-c5f9b5ccae24.pdf",
            "news_date": "2024-04-22 18:01:28"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Resignation of Company Secretary / Compliance Officer",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
            "news_body": "Resignation of Mr. Keyur Doshi as Company Secretary and Compliance Officer of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e4d7fff-21f2-4ce8-a7d9-1cc23b9b7495.pdf",
            "news_date": "2024-04-15 13:12:06"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 31st March 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=523b7d18-fe10-441c-be66-e9204b76983d.pdf",
            "news_date": "2024-04-08 17:47:14"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Reg. 7(3) \u2013 Compliance Certificate (RTA & Compliance Officer)",
            "caption": "Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulation, 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78874fdd-cd72-45e0-b3ef-4f389a4ecc9e.pdf",
            "news_date": "2024-04-08 17:41:35"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Additional details in reference to our letter dated 20th October 2023, are enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29d124e8-bf13-45df-95bf-974d7c77aee7.pdf",
            "news_date": "2024-03-27 12:17:53"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7d0e61d-989c-4f65-a14f-6132f8291f82.pdf",
            "news_date": "2024-03-21 16:09:57"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Unaudited Financial Results for 3rd Quarter and 9 Months ended 31 December 2023.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a53902b3-966b-4025-b2af-e7bf99ed9080.pdf",
            "news_date": "2024-02-13 13:00:42"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Board Meeting Outcome For Outcome Of Board Meeting Held On 12 February 2024",
            "news_body": "Outcome of Board Meeting held on 12 February 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27e5fefd-c7d2-41e3-a126-1c89d7b7146e.pdf",
            "news_date": "2024-02-12 17:40:37"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company 3Rd Quarter And 9 Month Ended 31St December 2023.",
            "news_body": "Please find enclosed herewith Unaudited Financial Results for 3rd Quarter and 9 Months ended 31st December 2023.",
            "news_id": "06040aa9-e471-4d3e-8d61-c8eab2444a29",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b139566d-2418-4530-ae75-bb43297b3814.pdf",
            "news_date": "2024-02-12 13:38:06",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company 3Rd Quarter And 9 Month Ended 31St December 2023.",
            "news_body": "Please find enclosed herewith Unaudited Financial Results for 3rd Quarter and 9 Months ended 31st December 2023.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b139566d-2418-4530-ae75-bb43297b3814.pdf",
            "news_date": "2024-02-12 13:38:06"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 2 February 2024",
            "news_body": "we are enclosing herewith Unaudited Financial Results of the Company along with limited review report issued by theStatutory Auditors of the Company for 3rd Quarter and 9 month ended 31st December 2023 which was taken on record at the Meeting of the Board of Directors of the Company held today at Mumbai.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2bbb98c3-d6c0-4deb-8b63-b4468c80108e.pdf",
            "news_date": "2024-02-12 13:35:09"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Revocation Of Stop Production Order From Andhra Pradesh Pollution Control Board",
            "news_body": "Intimation regarding revocation of Stop production order from Andhra Pradesh Pollution Control Board.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=092d8414-2a60-4117-9cc7-63c43327fc3c.pdf",
            "news_date": "2024-02-02 17:16:06"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting To Be Held On 12Th February 2024.",
            "news_body": "KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 ,inter alia, to consider and approve Unaudited Financial Results of the 3rd quarter and 9 months ended December 31, 2023 of the Financial year 2023-24.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0c99bb0-63c9-42d3-9f29-8e0fde1413f0.pdf",
            "news_date": "2024-01-19 12:00:51"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30(5) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015",
            "news_body": "Intimation attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5296ae94-bba2-4eb0-b166-050404194967.pdf",
            "news_date": "2024-01-17 16:30:04"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "The Board of Directors of the Company  in its Meeting held today has appointed Mr. Keyur Doshi as Company Secretary and Compliance officer of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d29858a2-71ae-4627-b6f1-992a691cc59a.pdf",
            "news_date": "2024-01-17 16:24:44"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 17Th January 2024",
            "news_body": "The Board of Directors of the Company in its meeting held today and on recommendation of Nomination and Remuneration Committee have considered and approved the appointment of Mr. Keyur Doshi (MembershipNumber: A32107) as Company Secretary, Compliance Officer & Key Managerial Personnel of the Company with effect from 17th January 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16404feb-3f56-4869-ad8f-dfaf23923cf1.pdf",
            "news_date": "2024-01-17 16:20:27"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Enclosed herewith a copy of Certificate received from KFIN Technologies  Limited. the Registrar and Share Transfer Agent of the Company, for the Quarter ended December 31, 2023.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1427033-a532-4e65-8a72-8e430822b305.pdf",
            "news_date": "2024-01-09 10:50:50"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "It is hereby informed that the trading window for the dealing in the Securities of the Company by the insiders shall remain closed with effect from close of business hours on December 31, 2023 and until 48 hours after the declaration of the Company''s un-audited financial results for the third Quarter and Nine Months ended December 31, 2023 of the financial year 2023-24.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10621c91-8997-402f-8fd6-a6a103398cb5.pdf",
            "news_date": "2023-12-21 13:10:19"
        },
        {
            "co_code": 3697,
            "bse_code": 524518,
            "isin": "INE268B01013",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Order Received From Andhra Pradesh Pollution Control Board",
            "news_body": "Order received from Andhra Pradesh Pollution Control Board",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f005d5ac-217d-470d-963e-2b613ebedd5d.pdf",
            "news_date": "2023-12-15 16:59:53"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The 2Nd Quarter And Half Year Ended 30Th September, 2023",
            "news_body": "Unaudited Financial Results for the 2nd quarter and half year ended 30th September, 2023",
            "news_id": "2264475d-56a5-4ffb-acfd-8ba9aa5cdc3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b8749e3-9415-4ee4-bdec-4f556c14122d.pdf",
            "news_date": "2023-11-08 14:38:31",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The 1St Quarter Ended June 30, 2023",
            "news_body": "Unaudited Financial Results of the Company for the 1st quarter ended June 30, 2023",
            "news_id": "1238ed05-487d-4bab-a73b-259fc1af682e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3785447-91b3-4807-b1df-fae5928dd67c.pdf",
            "news_date": "2023-08-09 16:17:19",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Under Regulation 30 & 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Further to our letter dated May 11, 2023 and in compliance with Regulation 30 read with Schedule III and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that the Board of Directors of the Company at its meeting held today have approved the following:<BR> 1. Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023 along with the Audit Report by the Statutory Auditors thereon - Enclosed.<BR> 2. Declaration in respect of Audit Report on the Financial Statement for the financial year ended March 31, 2023 with unmodified opinion from MD & CFO.<BR> <BR> The Meeting of the Board of Directors commenced at 12:30 pm and concluded at 3:45 p.m.<BR> <BR> The above is for your information and record.<BR>",
            "news_id": "5d24eebd-ceae-405a-9c5f-71486113b64e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a312cd57-79ef-4040-9cfc-fb110cffc170.pdf",
            "news_date": "2023-05-24 16:14:45",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Further to our letter dated May 11, 2023 and in compliance with Regulation 30 read with Schedule III and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that the Board of Directors of the Company at its meeting held today have approved the following:<BR> 1. Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023 along with the Audit Report by the Statutory Auditors thereon - Enclosed.<BR> 2. Declaration in respect of Audit Report on the Financial Statement for the financial year ended March 31, 2023 with unmodified opinion from MD & CFO.<BR> <BR> The Meeting of the Board of Directors commenced at 12:30 pm and concluded at 3:45 p.m.<BR> <BR> The above is for your information and record.  <BR>",
            "news_id": "839cd1c9-3c48-44a9-8da8-e6c4cabe27a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a647a7ea-1762-451b-8a75-381c4a4d45bd.pdf",
            "news_date": "2023-05-24 15:59:50",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For Quarter Ended 31.12.2022 With Digital Signature",
            "news_body": "Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review Report by the Statutory Auditors thereon.",
            "news_id": "628b3ba1-b87f-40a2-ad17-28fe9804e385",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edfeb6ff-fb71-44cf-b78a-f26728e1eea3.pdf",
            "news_date": "2023-02-03 18:37:46",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review Report by the Statutory Auditors thereon",
            "news_id": "3da428fc-39bc-4e29-91be-c1d006ed6ee6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=537be339-173d-47ee-9581-912ad871d14d.pdf",
            "news_date": "2023-02-03 15:47:00",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Further to our letter dated January 23, 2023 and in compliance with Regulation 30 read with Schedule III and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that the Board of Directors of the Company at its meeting held today have approved the agenda item as per the attached file.<BR> <BR> The Meeting of the Board of Directors commenced at 12:30 p.m. and concluded at 03:20 p.m.",
            "news_id": "adecec3b-af4f-49ee-a9d1-10fc1563af46",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=557dd7bd-fe03-4a9a-936c-66eb3724d88a.pdf",
            "news_date": "2023-02-03 15:39:10",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
            "news_id": "a8df147a-8893-4789-b0fd-6b75aa5f1828",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d34a4be9-569a-42f2-80e8-3e6b3be7b606.pdf",
            "news_date": "2022-11-24 17:19:13",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Q2fy23 Results",
            "news_body": "Q2Fy23 Results",
            "news_id": "c197a9d3-4f9c-47a6-8770-eb81f857039f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ba0ee3d-4e95-4d1d-b529-188f7419a59e.pdf",
            "news_date": "2022-11-10 16:14:50",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Q2FY23 Results",
            "news_body": "Q2FY23 Results",
            "news_id": "777396e7-1bbb-4773-9ca8-e0413e9e7cf0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d77c4928-c8a2-4179-b63f-1e5b037b8359.pdf",
            "news_date": "2022-11-10 16:07:56",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter Ended 30Th June, 2022",
            "news_body": "we herewith submit to the Exchange the quick results for the quarter ended 30th June, 2022 along with the Auditor- Limited review Report thereon  as approved by the Board of Directors at their meeting held on 1st August, 2022.<BR> .<BR>",
            "news_id": "73c4be49-6e88-4bfc-a84c-3c771507f085",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfaf13c3-9495-47b3-9d0f-ab64f6a758bf.pdf",
            "news_date": "2022-08-01 16:28:26",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Intimation To Stock Exchanges Under Regulation 30 Regards Outcome Of Board Meeting",
            "news_body": "We wish to inform the following outcome of the meeting of the Board of Directors held today, i.e. 1st August, 2022:<BR> <BR> (a) The un-audited financial results for the quarter ended 30th June, 2022 along with the Auditor's Limited Review Report thereon (Enclosed herewith) have been adopted by the Board.<BR> (b) The Board has taken note of the Resignation email of Ms.Taruni Banda, Company Secretary and Compliance officer dated June 27th, 2022, has accepted/approved the Resignation and relieved her from all responsibilities w.e.f 6th August, 2022.<BR> (c) The Board report and annexures have been approved for the 30th Annual General meeting. <BR>",
            "news_id": "7782d72e-9208-404d-8810-436f0a3075ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c179710e-480e-42b7-a111-62fe84fda9d8.pdf",
            "news_date": "2022-08-01 16:15:02",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "We herewith submit to you the disclosure of related party transactions for the half year ended 31st March 2022 as required under Reg. 23(9) of SEBI (LODR) Regulations, 2015.",
            "news_id": "96ff9d06-f866-486a-a0c4-ab16a4cb7c80",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b6575e3-bc2a-41fe-a9d7-78781ad66566.pdf",
            "news_date": "2022-05-27 11:23:05",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Quick Result. <BR> <BR>",
            "news_body": "We herewith submit to the Exchange the quick results for the quarter and year ended 31st March, 2022 along with the Auditor Report thereon (Enclosed herewith) as approved by the Board of Directors at their meeting held on 23rd May, 2022.",
            "news_id": "d6b75fe5-c01b-4d7f-ac42-e7bdb125a0d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e4f51d9-9de4-46c7-92a3-fb38db5b131f.pdf",
            "news_date": "2022-05-23 15:14:43",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "We wish to inform the following outcome of the meeting of the Board of Directors held today, i.e. 23rd May, 2022:<BR> <BR> (a) The audited financial results for the quarter and Year ended 31st March, 2022 along with the Auditor's Report thereon have been adopted by the Board.<BR> <BR>",
            "news_id": "04872861-551d-4ec3-9615-14198b119ea6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8abb307c-3559-48ce-b37c-cbf2e6e9851f.pdf",
            "news_date": "2022-05-23 15:04:58",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended 31St December, 2021",
            "news_body": "Unaudited financial results as approved by the Board of Directors for the quarter and three months ended 31st December, 2021 along with limited review report given by the Statutory Auditors",
            "news_id": "d82162b8-cbf4-4219-8b8c-81bf6146d739",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9fcaf68-d309-43c9-8a8c-36848c2c2571.pdf",
            "news_date": "2022-02-12 16:11:18",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2021",
            "news_body": "The Board of Directors in their meeting held on 12th February, 2022 have inter alia considered and approved the unaudited financial results for the quarter and nine months ended 31st December, 2021 and taken on record the limited review report issued by the Statutory Auditors of the Company",
            "news_id": "0971d219-65fd-4bc0-840b-172789e37f75",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec1fc2e9-8a4f-44ce-984f-740ac6a14575.pdf",
            "news_date": "2022-02-12 15:40:00",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Quarter And Half Year Ended 30Th September, 2021",
            "news_body": "We herewith submit to you the disclosure of related party transactions for the half year ended 30th September 2021 as required under Reg. 23(9) of SEBI (LODR) Regulations, 2015.",
            "news_id": "02988b92-3290-4750-b3fb-97caeaa44938",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=271c5159-20b2-4a90-99c5-5fec0f92b7f7.pdf",
            "news_date": "2021-11-09 14:47:47",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 9Th November, 2021",
            "news_body": "we wish to inform the following outcome of the meeting of the Board of Directors held today, i.e. 9th November, 2021:<BR> <BR> 1. The unaudited financial results for the quarter and half year ended 30th September 2021 along with the Limited Review Report thereon  have been adopted by the Board.<BR> <BR> 2. Appointment of Mr. Jitendra Shah (DIN: 09377846) as Additional Director, Non-Executive Category.<BR> <BR> 3.  The Board has taken note of Resignation of Mr. E J Babu (DIN: 06759124) as Director with effect from 10th November, 2021.<BR> <BR>",
            "news_id": "face8bf1-fba4-4743-b93e-3508fa36a5b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02ef3785-0f70-4293-8e0a-b5e5c0fafacb.pdf",
            "news_date": "2021-11-09 14:15:44",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Quick Results For The Quarter And Half Year Ended 30Th September, 2021",
            "news_body": "Quick results for the quarter and half year ended 30th September, 2021 along with the Limited Review Report thereon (Enclosed herewith) as approved by the Board of Directors at their meeting held on 9th November, 2021.",
            "news_id": "a59958fd-c275-4dbe-afe0-14a3b41157b3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5ce1b28-44dc-4cf1-9b02-52d57dde5d7c.pdf",
            "news_date": "2021-11-09 14:09:28",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Quick Result For Quarter 30Th June, 2021",
            "news_body": "We refer to the above mentioned subject, we herewith submit to the Exchange the quick results for the quarter ended 30th June, 2021 as approved by the Board of Directors at their meeting held on 30th July, 2021.",
            "news_id": "148ae819-cda7-46bc-8c82-acd53f6bf01f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=413f50a2-034f-4770-ad62-24d673c82d76.pdf",
            "news_date": "2021-07-30 15:33:06",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Out Come Of Board Meeting",
            "news_body": "we wish to inform the following outcome of the meeting of the Board of Directors held today, i.e. 30th July, 2021:<BR> <BR> (a) The Un-Audited financial results for the quarter ended 30th June, 2021 along with the Limited Review Report thereon (Enclosed herewith) have been adopted by the Board.<BR> (b) The Board has taken note of Resignation of Mr. Manish Jain, Director from the Board.<BR> (c) The Board has taken note of end of tenure of Mr. Avinash Ravi as Managing Director and accordingly Change in designation of Mr. Avinash Ravi from Managing Director to Non-Executive Director.<BR> (d) Appointment of Mr. Pabitra Bhattacharya as Additional Director and Managing Director of the Company subject to approval of members at the ensuing Annual General Meeting, whose Brief profile is attached herewith.<BR>",
            "news_id": "e4443001-3a11-4dca-a35e-63117856c6e8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc4324a6-318b-4cea-9682-404e2aa01129.pdf",
            "news_date": "2021-07-30 15:29:37",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Disclosure For Quarter And Year Ended 31St March, 2021",
            "news_body": "We herewith submit to you the disclosure of related party transactions for the half year ended 31st March 2021 as required under Reg. 23(9) of SEBi (LODR) Regulations, 2015",
            "news_id": "772418ea-0f33-4978-91ec-196c5ddf13a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=300acad5-ee31-49ac-8587-b7f81205dad5.pdf",
            "news_date": "2021-06-01 21:40:43",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Quick Result For FY 31St March, 2021",
            "news_body": "we herewith submit to the Exchange the quick result for the quarter and year ended 31st March, 2021 as approved by the Board of Directors at their meeting held on 27th May, 2021.<BR>  <BR>  <BR> <BR>",
            "news_id": "49308d32-18ec-4581-b5bd-8b01e5f17597",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0b23612-9e22-4b12-bf42-bf95f92d0fe0.pdf",
            "news_date": "2021-05-27 14:14:37",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Dated 27-05-2021",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ['SEBI LODR Regulations'], we wish to inform the following outcome of the meeting of the Board of Directors held today, i.e. 27th May, 2021:<BR> <BR> (a) The Audited financial results for the quarter and Year ended 31st March, 2021 along with the Auditor Report thereon (Enclosed herewith) have been adopted by the Board.<BR>",
            "news_id": "d575d625-3d96-4b8f-b19d-0588b55f989a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9004eb7-f775-459e-ad85-0e46f8ffa00e.pdf",
            "news_date": "2021-05-27 14:11:25",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}